Biosimilar and interchangeability finder

21 reference products have 107 licensed biosimilar products, 61 of them interchangeable. Pick a reference product for its biosimilars, dates and presentations.

  • Humira (adalimumab)

    10 biosimilars, 9 interchangeable: Amjevita, Cyltezo, Hyrimoz, Hadlima, Abrilada, Hulio, Yusimry, Yuflyma, Simlandi, Idacio

  • Eylea (aflibercept)

    6 biosimilars, 5 interchangeable: Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu, Eydenzelt

  • Avastin (bevacizumab)

    6 biosimilars, 0 interchangeable: Mvasi, Zirabev, Alymsys, Vegzelma, Avzivi, Jobevne

  • Xgeva (denosumab)

    20 biosimilars, 20 interchangeable: Jubbonti, Wyost, Ospomyv, Xbryk, Osenvelt, Stoboclo, Bomyntra, Conexxence, Bildyos, Bilprevda, Aukelso, Bosaya, Enoby, Xtrenbo, Jubereq, Osvyrti, Boncresa, Oziltus, Ponlimsi, Degevma

  • Soliris (eculizumab)

    2 biosimilars, 2 interchangeable: Bkemv, Epysqli

  • Procrit (epoetin alfa)

    1 biosimilar, 0 interchangeable: Retacrit

  • Enbrel (etanercept)

    3 biosimilars, 0 interchangeable: Erelzi, Erelzi Sensoready, Eticovo

  • Neupogen (filgrastim)

    5 biosimilars, 0 interchangeable: Zarxio, Nivestym, Releuko, Nypozi, Filkri

  • Simponi (golimumab)

    2 biosimilars, 2 interchangeable: Immgolis, Immgolis Intri

  • Remicade (infliximab)

    4 biosimilars, 0 interchangeable: Inflectra, Renflexis, Ixifi, Avsola

  • Novolog (insulin aspart)

    3 biosimilars, 2 interchangeable: Kirsty, Garzulys, Merilog

  • Lantus (insulin glargine)

    3 biosimilars, 3 interchangeable: Semglee, Rezvoglar, Langlara

  • Tysabri (natalizumab)

    1 biosimilar, 0 interchangeable: Tyruko

  • Xolair (omalizumab)

    1 biosimilar, 1 interchangeable: Omlyclo

  • Neulasta (pegfilgrastim)

    9 biosimilars, 0 interchangeable: Fulphila, Udenyca, Ziextenzo, Nyvepria, Fylnetra, Stimufend, Udenyca Onbody, Armlupeg, Ennumo

  • Perjeta (pertuzumab)

    1 biosimilar, 1 interchangeable: Poherdy

  • Lucentis (ranibizumab)

    5 biosimilars, 4 interchangeable: Byooviz, Cimerli, Nufymco, Ranluspec, Lucamzi

  • Rituxan (rituximab)

    4 biosimilars, 1 interchangeable: Truxima, Ruxience, Riabni, Zimrixby

  • Actemra (tocilizumab)

    5 biosimilars, 1 interchangeable: Avtozma, Tofidence, Tyenne

  • Herceptin (trastuzumab)

    6 biosimilars, 0 interchangeable: Ogivri, Herzuma, Ontruzant, Trazimera, Kanjinti, Hercessi

  • Stelara (ustekinumab)

    10 biosimilars, 10 interchangeable: Wezlana, Selarsdi, Pyzchiva, Otulfi, Imuldosa, Yesintek, Steqeyma, Starjemza

Source: FDA Purple Book data download, October 2026; licensed CDER products. Updated monthly.

For licensed clinicians. Use with clinical judgment.